Respiratory syncytial virus in adults with comorbidities: an update on epidemiology, vaccines, and treatments
Clinical Microbiology and Infection · 2023-12 · 29 (12) · 1538-1550
DOI: 10.1016/j.cmi.2023.08.028 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Microbiology and Infection, 2023-12. Verfasst von Donia Bouzid und 5 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, INSERM UMR1137, IAME, F-75018, Paris, France; AP-HP Nord, Emergency Department, Bichat-Claude Bernard University Hospital, Par…. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus, Human, Respiratory Syncytial Virus Vaccines. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 80 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Respiratory syncytial virus (RSV) is widely known as a frequent cause of respiratory distress among adults, particularly in older people. Recent years have witnessed several improvements in respiratory virus detection, leading to more questions about therapeutic management strategies. OBJECTIVES: This narrative review focuses on the RSV burden in older people and adults with risk factors and provides an update on the main recent developments regarding managing this infection. SOURCES: A comprehensive PubMed search was conducted till August 2023 to identify studies on RSV among the adult population. We included observational studies, RCTs on vaccines, and different therapies. CONTENT: This review should give clinicians an overview of RSV epidemiology and burden among older people and adults with pre-existing risk factors, the most recent randomized clinical trials on RSV vaccines, and the existing data on the different therapeutics existing and under development. IMPLICATIONS: There is a growing body of evidence on RSV burden in adults. The landscape of preventive and curative treatments is quickly evolving.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université Paris Cité, INSERM UMR1137, IAME, F-75018, Paris, France; AP-HP Nord, Emergency Department, Bichat-Claude Bernard University Hospital, Paris, France.
- Laboratoire Cerba, Infectious Diseases Department, Saint Ouen l'Aumône, France.
- Université Paris Cité, INSERM UMR1137, IAME, F-75018, Paris, France; AP-HP Nord, Infectious Diseases Department, Bichat-Claude Bernard University Hospital, Paris, France.
- Université Paris Cité, INSERM UMR1137, IAME, F-75018, Paris, France; AP-HP Nord, Virology Department, Bichat-Claude Bernard University Hospital, Paris, France.
- Université de Montpellier, VBMI, Inserm U1047, Nîmes, France; Department of Infectious and Tropical Diseases, CHU Nîmes, Université de Montpellier, Nîmes, France. Electronic address: paul.loubet@chu-nimes.fr.
Zitieren
APA
Bouzid, D., Visseaux, B., Ferré, V. M., Peiffer-Smadja, N., Le Hingrat, Q., & Loubet, P. (2023). Respiratory syncytial virus in adults with comorbidities: an update on epidemiology, vaccines, and treatments. Clinical Microbiology and Infection, 29(12), 1538-1550. https://doi.org/10.1016/j.cmi.2023.08.028
Vancouver
Bouzid D, Visseaux B, Ferré VM, Peiffer-Smadja N, Le Hingrat Q, Loubet P. Respiratory syncytial virus in adults with comorbidities: an update on epidemiology, vaccines, and treatments. Clinical Microbiology and Infection. 2023;29(12):1538-1550. doi:10.1016/j.cmi.2023.08.028
BibTeX
@article{Bouzid2023,
author = {Bouzid, Donia and Visseaux, Benoit and Ferré, Valentine Marie and Peiffer-Smadja, Nathan and Le Hingrat, Quentin and Loubet, Paul},
title = {Respiratory syncytial virus in adults with comorbidities: an update on epidemiology, vaccines, and treatments},
journal = {Clinical Microbiology and Infection},
year = {2023},
volume = {29},
number = {12},
pages = {1538--1550},
doi = {10.1016/j.cmi.2023.08.028}
}
EUVIMED